Latest Ratios: P/E Ratio -1.0x · EV/EBITDA N/A · ROE N/A. (2004–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $8M | $9M | $20M | $22M | $49M | $46M | $47M | $26M | $16M | $46M | $54M |
| Enterprise Value | $14M | $47M | $16M | $-1745860 | $170M | $171M | $166M | $101M | $92M | $158M | $237M |
| P/E Ratio → | -1.01 | — | 0.95 | 0.39 | — | — | — | — | — | — | — |
| P/S Ratio | 0.59 | 0.10 | 0.17 | 0.23 | 0.93 | 0.99 | 0.90 | 0.28 | 1.25 | — | 0.16 |
| P/B Ratio | — | — | — | — | — | — | — | — | — | 0.41 | 0.25 |
| P/FCF | — | — | — | — | 18.23 | — | — | — | — | — | 1.75 |
| P/OCF | — | — | — | — | 14.78 | — | — | — | — | — | 1.13 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.52 | 0.14 | -0.02 | 3.24 | 3.69 | 3.16 | 1.10 | 7.14 | — | 0.71 |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | 0.81 | -0.03 | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | 63.79 | — | — | — | — | — | 7.65 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 7.0% | 7.0% | 14.2% | 18.5% | 30.8% | 27.6% | 6.7% | -13.9% | 45.5% | — | 22.7% |
| Operating Margin | -58.9% | -58.9% | -32.3% | -16.1% | -24.5% | -297.1% | -120.9% | -60.9% | -274.8% | — | -18.3% |
| Net Profit Margin | -58.4% | -58.4% | 18.3% | 59.3% | -11.9% | -197.2% | -195.8% | -71.0% | -1188.7% | — | -19.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | — | — | — | — | -343.6% | -45.7% | -25.7% |
| ROA | -45.9% | -45.9% | 11.2% | 29.6% | -4.9% | -49.0% | -39.9% | -19.0% | -40.7% | -12.6% | -7.0% |
| ROIC | — | — | — | — | — | — | -102.5% | -74.9% | -19.2% | -16.4% | -10.1% |
| ROCE | — | — | — | — | — | — | -139.2% | -1002.4% | -37.8% | -30.1% | -19.8% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | — | — | — | — | 1.02 | 1.08 |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | — | — | — | — | — | — | — | — | 1.00 | 0.84 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | 45.56 | — | — | — | — | — | 5.90 |
| Interest Coverage | -20.25 | -20.25 | 13.39 | 64.98 | -1.57 | -7.95 | -16.67 | -12.92 | -5.71 | -12.53 | -8.60 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.44 | 0.44 | 0.54 | 0.45 | 0.28 | 0.20 | 0.36 | 0.28 | 0.50 | 0.66 | 0.78 |
| Quick Ratio | 0.20 | 0.20 | 0.47 | 0.41 | 0.27 | 0.19 | 0.29 | 0.16 | 0.31 | 0.65 | 0.18 |
| Cash Ratio | 0.11 | 0.11 | 0.05 | 0.08 | 0.06 | 0.05 | 0.13 | 0.01 | 0.00 | 0.02 | 0.09 |
| Asset Turnover | — | 0.91 | 0.86 | 0.39 | 0.39 | 0.39 | 0.21 | 0.35 | 0.03 | — | 0.38 |
| Inventory Turnover | 2.36 | 2.36 | 7.56 | 5.83 | 17.28 | 8.04 | 3.61 | 3.69 | 0.09 | — | 0.70 |
| Days Sales Outstanding | — | 55.96 | 40.79 | 3.34 | 199.55 | 126.64 | 176.66 | 139.66 | 3656.66 | — | 0.53 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | 0.9% | 5.0% | — | — | — | — | — | — |
| Payout Ratio | — | — | — | 0.4% | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 105.3% | 254.7% | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | 5.5% | — | — | — | — | — | 57.1% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.9% | 5.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $7M | $6M | $7M | $6M | $6M | $5M | $4M | $3M | $3M | $2M |
Regulatory and liquidity dependency
According to current market data, SEED trades at a P/S multiple of 0.56, which appears to reflect speculative interest in biotech potential rather than the underlying financial performance of a company currently reporting negative operating margins and a significant year-over-year revenue decline of 19.48%.
The negative P/E ratio of -0.98 confirms that traditional earnings-based valuation metrics are currently inapplicable due to the firm's inability to achieve profitability. Investors appear to be pricing the stock as a binary call option on future GMO commercialization, ignoring the structural risks associated with the company's current loss-making distribution model.
As reported in financial statements, the company's gross margin has fluctuated significantly, reaching -9.0% in the most recent quarter, which suggests that the firm lacks the pricing power necessary to cover its cost of goods sold in a highly competitive agricultural input market.
The operating margin of -153.8% indicates that the company's fixed cost base, likely driven by R&D and logistical overhead, is entirely disproportionate to its current revenue scale. This level of margin compression suggests that the business model is currently failing to translate its intellectual property into a sustainable commercial advantage.
Based on recent quarterly filings, the cash conversion cycle has expanded to 867 days, reflecting a severe deterioration in working capital management compared to historical norms and suggesting that the company is struggling to convert its inventory into cash within a reasonable timeframe.
The dramatic increase in days inventory outstanding to 719 days highlights a significant risk of inventory obsolescence, which is particularly dangerous for a seed company with perishable products. This inefficiency, combined with a high DSO, indicates that the company is effectively financing its customers and suppliers while its own cash reserves are rapidly depleting.
According to the latest balance sheet data, the company maintains a current ratio of 0.44, which, when paired with a quick ratio of 0.20, indicates a precarious liquidity position that leaves the firm highly vulnerable to short-term operational shocks or sudden capital requirements.
The reliance on a limited cash balance of approximately $15.9 million to fund ongoing operations suggests that the company may face an imminent liquidity crisis if it cannot secure additional external financing. This lack of a safety margin warrants extreme caution, as the firm's ability to meet its short-term obligations appears increasingly dependent on non-operational cash inflows.
Investors frequently misapply biotech-style valuation multiples to SEED, failing to recognize that the company currently functions more like a struggling agricultural distributor than a high-margin intellectual property licensor, thereby obscuring the fundamental risks inherent in its current revenue and cost structure.
The use of revenue-based multiples is particularly misleading here, as it ignores the low-quality nature of the top-line growth and the potential for gross-versus-net revenue accounting distortions. Analysts should instead focus on cash burn rates and the sustainability of the R&D pipeline, as these metrics provide a more accurate assessment of the company's survival prospects than traditional valuation ratios.
Includes 30+ ratios · 22 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SEED stock.
Origin Agritech Limited's current P/E ratio is -1.0x. The historical average is 3.7x.
Based on historical data, Origin Agritech Limited is trading at a P/E of -1.0x. Compare with industry peers and growth rates for a complete picture.
Origin Agritech Limited has 7.0% gross margin and -58.9% operating margin.